VERV
Verve Therapeutics
VERV
VERV
Delisted
VERV was delisted on the 24th of July, 2025.
157 hedge funds and large institutions have $1.05B invested in Verve Therapeutics in 2023 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 68 increasing their positions, 26 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
1.79% less ownership
Funds ownership: 100.25% → 98.46% (-1.8%)
11% less call options, than puts
Call options by funds: $3.63M | Put options by funds: $4.06M
Holders
157
Holding in Top 10
3
Calls
$3.63M
Puts
$4.06M
Top Buyers
| 1 | +$27.9M | |
| 2 | +$25.4M | |
| 3 | +$25.1M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$20.2M |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
+$17.4M |
Top Sellers
| 1 | -$43.7M | |
| 2 | -$8.86M | |
| 3 | -$6.24M | |
| 4 |
AG
Artal Group
Luxembourg
|
-$3.98M |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$3.78M |